focus -WSS

focus

author：comprehensive 2025-09-30 00:03:56 - browse：7922

U.S. President Joe Biden stands with his fingers locked next to an US flag — politics coverage from STAT — President Biden's White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs.

WASHINGTON — The White House on Monday ballyhooed a routine step in Medicare’s new program to negotiate the prices of prescription drugs, its latest effort to draw attention to the program in an election year.

The news is not controversial: The pharmaceutical companies that make the first ten drugs up for negotiation all submitted counteroffers. It’s an incremental step in the new program, which was created in 2022.

Earlier this year, Medicare sent its initial price offers to the companies. Neither the Biden administration nor the drug manufacturers have volunteered any information about the White House’s initial price offers or the counteroffers. The process is scheduled to end by Aug. 1.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： A solution to the after

hotspot

WSS

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

NIH study of ME/CFS points to clear biological hallmarks

Welsh Carson private equity firm escapes from FTC antitrust case

Class action alleges UnitedHealth concealed DOJ probe

Alabama IVF ruling threatens families facing fatal genetic disease

Empower primary care with adequate payments and technology

entertainment

focus

hotspot

Medicare details structure of new drug price negotiation program

Brain MRIs reveal impact of 'toxic stress' on Black children

What does generative AI mean for health care? We asked experts

Chemotherapy before breast cancer surgery might fuel metastasis

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Has Bernie Sanders reached the limit of his pharma bullying effort?

Medical records are filled with copy

Crowdfunding for medical bills sidesteps core problem, author says

New air purifier tech could be key to improving indoor air quality

Brain technologies pose threats that are all too real, experts warn

focus

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

The effects of a landmark ruling on DNA ownership are becoming clearer

Antivenom research: Lessons from HIV applied in search for universal antidote

Novel spinal cord stimulator treats paralysis without surgery

Antivenom research: Lessons from HIV applied in search for universal antidote

Lawmakers grill UnitedHealth CEO on Change cyberattack

knowledge

Wikipedia

hotspot

focus